Seminoma screening

Seminoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Seminoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging TNM Stage Grouping
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy Treatment - Stage I Treatment - Stage II Treatment - Stage III Treatment - Recurrent
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Seminoma screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Seminoma screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Seminoma screening
CDC on Seminoma screening
Seminoma screening in the news
Blogs on Seminoma screening
Directions to Hospitals Treating Seminoma
Risk calculators and risk factors for Seminoma screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Overview

According to the 'KIT Mutations Are Common in Testicular Seminomas' study, screening for seminoma by using the highly sensitive combination of denaturing high performance liquid chromatography (HPLC) and direct sequencing.

Screening

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:

• Mutations of KIT exon 17
• D816H mutation
• Y823D mutation

References

[[Category:Oncology]